Citadel Advisors
MGRX icon

Citadel Advisors’s Mangoceuticals MGRX Stock Holding History

Citadel Advisors’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
+338,964
New +$131K ﹤0.01% 12480
2024
Q3 		– Sell
-8,880
Closed -$41.2K – 14843
2024
Q2 		$41.2K Buy
8,880
+1,253
+16% +$5.8K ﹤0.01% 11963
2024
Q1 		$25.2K Buy
7,627
+6,140
+413% +$24.4K ﹤0.01% 12844
2023
Q4 		$6.18K Sell
1,487
-1,658
-53% -$14.7K ﹤0.01% 13369
2023
Q3 		$41.5K Buy
+3,145
New +$58.9K ﹤0.01% 11965

Other funds holding MGRX

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors's MGRX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Mangoceuticals (MGRX) in Q2 2026: 338,964 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #12480 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in MGRX as recently as Q2 2024.

Citadel Advisors first reported a position in MGRX in Q3 2023 and has held it in 5 quarters since. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Citadel Advisors held 338,964 shares of Mangoceuticals worth $129K as of Q2 2026.
  • Mangoceuticals was a new Citadel Advisors position in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12480 holding.
  • Citadel Advisors first reported a position in Mangoceuticals in Q3 2023 and has held it in 5 quarters since.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.